The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,009–1,032 of 11,281
ArticlePsilocybin

Psilocybin-induced behavioral and cellular effects.

Dong AM, Han Y, Xu Z +2

Europe PMC2026
PreprintKetamine

S-ketamine, but not R-ketamine, transiently suppresses front-loaded binge-like alcohol self-administration in male rats

Hilal FF, Dreinaza M, Lebel Q +3

Europe PMC2026
ArticleMDMA

Australian University Residential College Students' Awareness of and Attitudes Toward Drug Checking Services.

Pocuca N, Barnett A, Alcorn C +4

Europe PMC2026
ArticleMDMA

Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA.

Semple MG, Mennenga SE, Smith R +6

Europe PMC2026
ArticleMDMA

Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder.

Williams MT, Faber SC, Sloshower J +2

Europe PMC2026
ArticleKetamine

Ketamine for Cancer-Related Pain in Palliative Care: A Systematic Review of Clinical Use and Safety.

Vitorino-Afonso C, Reis-Pina P

Europe PMC2026
ArticleMDMA

Dermatological manifestations associated with chemsex.

Balado-Simó P, Gimeno-Ribes E, Riera-Monroig J +2

Europe PMC2026
ArticleKetamine

Comparison of Esketamine and Remifentanil Combined With Propofol for Painless Fiberoptic Bronchoscopy: A Randomized Controlled Trial.

Fan X, Li L, Shi J +1

Europe PMC2026
ArticleKetamine

Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.

Lin C, Wang X

Europe PMC2026
ArticleDMT

Advancing Next-Generation Psychedelic Therapeutics through Selective 5‑HT2A Activation, Precision Aerosol Delivery, and Optimized 5‑MeO-DMT Treatment Paradigms.

Renner AC, Kargbo RB

Europe PMC2026
ArticlePsilocybin

Psychedelics produce enduring enhancement of reward responsiveness in male rats.

Thomas CW, LaMalfa KS, Whelan TP +6

Europe PMC2026
PreprintKetamine

Subacromial Ketamine Injection for Pain in Rotator Cuff Tendinopathy: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Lian OM, Husby VKS, Ackermann P +5

Europe PMC2026
ProjectPsilocybin

Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit

OSF2026
TrialPsilocybin

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

ClinicalTrials.gov2026
ArticleKetamine

Ultrasound-Guided Femoral Nerve Block with Esketamine Adjuvant for Postoperative Analgesia in Total Knee Arthroplasty-A Randomized, Double-Blind, Controlled Trial.

Cheng Z, Hong L, Wang Y +1

Europe PMC2026
ArticleKetamine

Ketamine-induced cystitis: Lessons from a case of recreational use.

Jhawar A, Elfessi Z

Europe PMC2026
PreprintPsychedelics

Strengthening the Psychedelic Safety Net: A Call for a Coordinated Ecosystem of Post-Psychedelic Care

Jurlando C, Nash K, Masah DJ +2

Europe PMC2026
TrialKetamine

Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP

ClinicalTrials.gov2026
ArticleMDMA

Understanding Consumption of Illicit Drugs and New Psychoactive Substances in Australia by Triangulating Drug Checking and Wastewater-Based Epidemiology.

Usman M, McLeod M, Nadarajan D +6

Europe PMC2026
ArticlePsychedelics

Personality changes following first-time psychedelic use in college students in Germany.

Volkmann C, Seitz M, Evens R +3

Europe PMC2026
ArticleKetamine

Large-Scale Forensic Surveillance of Seized E-Liquids Reveals an Emerging Etomidate-Analog-Centered Vaping Trend in Eastern Taiwan.

Lin HR

Europe PMC2026
PreprintDMT

In Silico Characterization of Desmodium gangeticum Compounds as Dual Modulators of MAO-B and 5- HT2A in Parkinson’s Disease: An Integrated Approach Combining Molecular Docking, ADMET Profiling, MM-GBSA, QSAR Modeling, and Molecular Dynamics Simulation

Akinma OE, Akinola OA, Ojo ID +5

Europe PMC2026
ArticleIbogaine

Psychedelics and the thalamocortical system: A scoping review.

Villalba S, Christensen AM, Di Costanzo L +4

Europe PMC2026
ArticlePsilocybin

Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.

Gagnon F, Philibert A, Carignan B +2

Europe PMC2026